Asia In the past year, PharmaBoardroom has spoken to several of the most impressive female pharma leaders working in Asia today. These women are breaking new ground and managing some of Big Pharma’s most important global affiliates. Here, five of Asian pharma’s top female executives give exclusive insights into their successes…

Opinion Krishna Cheriath, chief data officer at BMS, outlines the ways in which AI is already transforming the delivery of healthcare, what modern biopharma companies’ AI innovation agendas should include, and why behavioural change is a key tenet in securing meaningful health outcomes with AI.   As Biopharma increases AI investments,…

Taiwan With the USA and China locked in a trade war, China’s near neighbour Taiwan – with its strong scientific and technology base, political security and economic reliability – may stand to benefit from the situation, attracting more investment from the US and more closely collaborating with US firms and research…

China The US FDA has granted orphan drug designation to Shanghai-headquartered biotech CARsgen Therapeutics’ CAR-T cell therapy CT053 for multiple myeloma after positive results were observed in the phase I trial efficacy evaluation.   19 of 24 patients with relapsed and refractory multiple myeloma showed complete response Zonghai Li, CARSgen Therapeutics…

Puerto Rico Puerto Rico has long been known for its pharma manufacturing prowess, but multinational companies are increasingly looking to conduct clinical trials there, thanks to strong institutional support, a strong example set by R&D-focused university spin-off companies, and the island’s unique ethnic profile.   The Hispanic population has been historically underrepresented…

Canada Diabetes Canada’s Jan Hux outlines how her organization has been able to shift from small, local programs to driving change at a much larger level via a ‘collective impact’ approach.   When I encountered the concept of collective impact in the Stanford Social Innovation Review, I realized the possibilities lay…

Algeria Yacine Sellam, president of the Algerian Society for Regulatory Affairs & Pharmacoeconomics, looks at how European countries such as France and Belgium have countered medicine supply shortages and how Algeria can implement these solutions to address its own drug shortage issue.    This situation is not unique to Algeria. Medicine…

Egypt As Egypt rolls out Universal Health Insurance with the aim of achieving full coverage between 2030 and 2035, the domestic pharmaceutical market stands to see significant long-term shifts. As self-medication is currently the cheapest form of treatment, out-of-pocket expenditures make up 62 percent of total health expenditure; a number which…

Egypt Amro Kandil, managing director Northeast Africa for GE Healthcare, outlines how his affiliate has grown to be the partner of choice for the Egyptian government as it seeks to improve the level of medical technology available in institutions throughout Egypt.    GE Healthcare has invested in the oncology team in…

Company Profile As one of the longest-standing multinational companies in Egypt, French pharmaceutical giant Sanofi aims to plays a major role in ensuring access to innovative pharmaceuticals for the Egyptian population through manufacturing locally.   During President Macron’s visit, Sanofi signed a Memorandum of Understanding (MoU) with the Egyptian Ministry of Health…

Opinion Janssen Australia & New Zealand’s Bruce Goodwin argues that greater adoption of patient-centric practices is beneficial to patients, companies and healthcare systems as a whole. Goodwin also gives his five fundamental pillars to adopting a patient-centric approach.    We know that patient-centricity not only aids better healthcare, it also has…

Opinion Bayer’s Michael Levy examines how artificial intelligence (AI) can assist in both the routine and advanced analytical tasks involved in conducting pharmacovigilance and therefore better ensure the safety of pharmaceuticals and the health of patients.   Pharmacovigilance or Patient Safety aims to promote and protect the health and well-being of…